Trans Asia Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 19-12-2024
- Paid Up Capital ₹ 5.00 M
as on 19-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 9.84%
(FY 2020)
- Profit 287.31%
(FY 2020)
- Ebitda 14.35%
(FY 2020)
- Net Worth 4.18%
(FY 2020)
- Total Assets 16.80%
(FY 2020)
About Trans Asia Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kuldeep Gupta, Veena Gupta, Raj Suri, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85100JK2010PTC003177
- Company No.
003177
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Trans Asia Labs?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kuldeep Gupta | Managing Director | 02-Jun-2010 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sorabh Gupta | Director | 08-May-2015 | Current |
Veena Gupta | Director | 29-Jul-2010 | Current |
Raj Suri | Director | 23-Sep-2011 | Current |
Gaurav Gupta | Director | 08-May-2015 | Current |
Manav Gupta | Director | 08-May-2015 | Current |
Financial Performance of Trans Asia Labs.
Trans Asia Labs Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.84% increase. The company also saw a substantial improvement in profitability, with a 287.31% increase in profit. The company's net worth moved up by a moderate rise of 4.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Trans Asia Labs?
In 2020, Trans Asia Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- K V Medicare & Diagnostics Private LimitedActive 11 years 10 months
Kuldeep Gupta, Veena Gupta and 3 more are mutual person
- Jammu Healthcare & Diagnostics Private LimitedActive 17 years 5 months
Kuldeep Gupta, Veena Gupta and 3 more are mutual person
- Grams Hospitals Private LimitedActive 17 years 1 month
Kuldeep Gupta, Sorabh Gupta and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trans Asia Labs?
Trans Asia Labs has a workforce of 16 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trans Asia Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trans Asia Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.